Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs

Christopher M Jones; Wilson M Compton; Beth Han; Grant Baldwin; Nora D Volkow

doi:10.1001/jamapsychiatry.2022.1776

Methadone-Involved Overdose Deaths in the US Before and After Federal Policy Changes Expanding Take-Home Methadone Doses From Opioid Treatment Programs

JAMA Psychiatry. 2022 Sep 1;79(9):932-934. doi: 10.1001/jamapsychiatry.2022.1776.

Authors

Christopher M Jones¹, Wilson M Compton², Beth Han², Grant Baldwin¹, Nora D Volkow²

Affiliations

¹ National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
² National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland.

Abstract

This observational study assesses whether methadone-involved overdose deaths decreased when opioid treatment programs take-home policies changed during the COVID-19 pandemic.

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Analgesics, Opioid / therapeutic use
Drug Overdose* / prevention & control
Humans
Methadone / therapeutic use
Opiate Overdose*
Opiate Substitution Treatment
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / rehabilitation
Policy

Substances

Analgesics, Opioid
Methadone

Grants and funding

CC/CDC HHS/United States